Doctor profile · Federal record
Dr. David Boyer, MD
Ophthalmology Physician (CMS: Ophthalmology) · Los Angeles, CA
- NPI 1295736916
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 54 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1245 Wilshire Blvd Ste 380
Los Angeles, CA 900174886
(213) 483-8810
fax (213) 975-9118
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- January 23, 2020
- Year of graduation
- 1972 — 54 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- California #G25107
- Medicaid
- CA #00G251070
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295736916. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
59,279
Distinct HCPCS
10
Medicare allowed
$7,118,099
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 34,740 | 108 | $37 | |
92134 |
Imaging of retina | 6,467 | 2,397 | $45 | |
67028 |
Injection of drug into eye | 3,187 | 661 | $138 | |
J0178 |
Injection, aflibercept, 1 mg | 2,688 | 257 | $868 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 2,670 | 85 | $151 | |
92014 |
Established patient complete exam of visual system | 2,564 | 1,728 | $142 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 1,510 | 68 | $228 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,495 | 100 | $272 | |
92012 |
Established patient problem focused exam of visual system | 1,103 | 625 | $101 | |
J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg | 658 | 41 | $199 |
In context: peer comparison
Among 92 peers in Los Angeles Ophthalmology Physician, average services per provider: 277. This provider delivers 214× the peer median.Open Payments
Industry payments received
All-time total
$141,884
Transactions
58
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EyePoint Pharmaceuticals US, INC. | 4 | $102,767.46 | |
| Genentech USA, INC. | 7 | $8,693.52 | |
| Regeneron Pharmaceuticals, INC. | 6 | $8,548.00 | |
| Apellis Pharmaceuticals, INC. | 5 | $6,007.52 | |
| Regeneron Healthcare Solutions, INC. | 1 | $4,232.00 | |
| Boehringer Ingelheim International GmbH | 2 | $3,575.00 | |
| Glaukos Corporation | 4 | $2,350.00 | |
| Abbvie INC. | 12 | $1,735.67 | |
| Bausch & Lomb Americas INC. | 5 | $1,191.48 | |
| BioCryst Pharmaceuticals, INC. | 1 | $1,053.75 | |
| Samsung Bioepis Co., LTD. | 1 | $810.00 | |
| Ocular Therapeutix, INC. | 4 | $443.10 | |
| Alcon Vision LLC | 2 | $278.22 | |
| Sandoz INC. | 3 | $184.57 | |
| Biogen, INC. | 1 | $13.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,153
Patients
399
Total drug cost
$82,568
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 216 | 58 | $2,802 |
| Ketorolac Tromethamine | Generic | 174 | 84 | $5,331 |
| Prednisolone Acetate | Generic | 143 | 72 | $7,670 |
| Brimonidine Tartrate | Generic | 115 | 33 | $4,693 |
| Timolol Maleate | Generic | 94 | 20 | $1,229 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 93 | 33 | $2,248 |
| Prolensa (Bromfenac Sodium) | Brand | 48 | 13 | $22,153 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 42 | 0 | $12,061 |
| Moxifloxacin (Moxifloxacin Hcl) | Brand | 38 | 21 | $1,626 |
| Dorzolamide Hcl | Generic | 37 | 21 | $763 |
Frequently asked questions
What is Dr. David Boyer's medical specialty?
Dr. David Boyer practices Ophthalmology Physician in Los Angeles, CA.
Where does Dr. David Boyer practice?
Dr. David Boyer practices at 1245 Wilshire Blvd Ste 380, Los Angeles, CA 900174886. Office phone: 2134838810.
What is Dr. David Boyer's NPI?
Dr. David Boyer's National Provider Identifier (NPI) is 1295736916, issued by NPPES.
Does Dr. David Boyer accept Medicare assignment?
Yes. Dr. David Boyer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Boyer commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection of drug into eye (HCPCS 67028). Source: CMS Medicare Physician & Other Practitioners file.